Knott David M Jr

Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$182.8M2026 Q3
Positions80
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.66.7%

Knott David M Jr reported 80 positions worth $182.8M as of September 30, 2026 (13F filed November 12, 2026). Largest holding: GOOG (17.0%). Biggest move: reduce IOVA ($6.4M).

10 / 80 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 GOOGAlphabet$31.2M17.04%91,420——-17.5%
▸ 2 APOApollo Global Management$26.1M14.28%225,000——+3.4%
▸ 3 IOVAIovance Biotherapeutics$17.3M9.44%1,165,000——-49.1%
▸ 4 XERSXeris Biopharma$9.6M5.24%1,002,900——+74.7%
▸ 5 SNDXSyndax Pharmaceuticals$8.1M4.40%428,294——-49.7%
▸ 6 TVTXTravere Therapeutics$7.7M4.18%129,967——-15.6%
▸ 7 BBIOBridgeBio Pharma$6.6M3.60%100,000——+17.6%
▸ 8 JPMJPMorgan Chase$5.8M3.15%17,409——+2.2%
▸ 9Lpl FinancialLPL Financial$5.0M2.76%16,500———
▸ 10 JAAAJanus Henderson AAA$4.7M2.58%93,528———

Pro Feature

The remaining 70 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Knott David M Jr hold as of Q3 2026?

Knott David M Jr reported 80 positions worth $182.8M in its Q3 2026 13F filing. Largest positions: GOOG (17.0%), APO (14.3%), IOVA (9.4%), XERS (5.2%) and SNDX (4.4%).

What did Knott David M Jr buy in Q3 2026?

New positions: ORKA, COLL, DYN, DWDPEUR and EWTX (8 in all). Added to: ELVN, COGT, CDNA, RCUS and BBIO (12 in all).

What did Knott David M Jr sell in Q3 2026?

Reduced: IOVA, PTGX, AGIO, TVTX and RZLT (18 in all). Sold out entirely: Catalyst Pharmaceuticals, Inc., ATRC, ARDX, RARE and VERA (12 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.